Metoprololo (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metoprololo" in Italian language version.

refsWebsite

Global rank Italian rank

17nih.gov

4^th place

9^th place

6doi.org

2^nd place

7^th place

5oadoi.org

799^th place

22^nd place

4google.it

215^th place

4^th place

3archive.org

6^th place

8^th place

1drugs.com

399^th place

1,563^rd place

1tga.gov.au

3,984^th place

low place

1who.int

195^th place

342^nd place

1clincalc.com

3,912^th place

low place

archive.org

V. Kühlkamp, A. Schirdewan; K. Stangl; M. Homberg; M. Ploch; OA. Beck, Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study., in J Am Coll Cardiol, vol. 36, n. 1, Lug 2000, pp. 139-46, PMID 10898425.
DL. Geffner, JM. Hershman, Beta-adrenergic blockade for the treatment of hyperthyroidism., in Am J Med, vol. 93, n. 1, Lug 1992, pp. 61-8, PMID 1352658.
G. Boriani, M. Biffi; E. Strocchi; A. Branzi, Nightmares and sleep disturbances with simvastatin and metoprolol., in Ann Pharmacother, vol. 35, n. 10, Ott 2001, p. 1292, PMID 11675864.

clincalc.com

Metoprolol - Drug Usage Statistics, ClinCalc DrugStats Database, su clincalc.com. URL consultato il 1º luglio 2020.

doi.org

dx.doi.org

Jennifer L. Isenhour e John A. Marx, Rosen's Emergency Medicine – Concepts and Clinical Practice, Elsevier, 2010, pp. 414–434, ISBN 978-0-323-05472-0. URL consultato il 1º luglio 2020.
HC. Swaisland, M. Ranson; RP. Smith; J. Leadbetter; A. Laight; D. McKillop; MJ. Wild, Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol., in Clin Pharmacokinet, vol. 44, n. 10, 2005, pp. 1067-81, DOI:10.2165/00003088-200544100-00005, PMID 16176119.
CM. Blake, ED. Kharasch; M. Schwab; P. Nagele, A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics., in Clin Pharmacol Ther, vol. 94, n. 3, Set 2013, pp. 394-9, DOI:10.1038/clpt.2013.96, PMID 23665868.
SD. Silberstein, S. Holland; F. Freitag; DW. Dodick; C. Argoff; E. Ashman, Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society., in Neurology, vol. 78, n. 17, Apr 2012, pp. 1337-45, DOI:10.1212/WNL.0b013e3182535d20, PMID 22529202.
RS. Bahn Chair, HB. Burch; DS. Cooper; JR. Garber; MC. Greenlee; I. Klein; P. Laurberg; IR. McDougall; VM. Montori; SA. Rivkees; DS. Ross, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists., in Thyroid, vol. 21, n. 6, Giu 2011, pp. 593-646, DOI:10.1089/thy.2010.0417, PMID 21510801.
AI. Ahmed, P. van Mierlo; P. Jansen, Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol., in Gen Hosp Psychiatry, vol. 32, n. 6, pp. 646.e5-7, DOI:10.1016/j.genhosppsych.2010.04.008, PMID 21112460.

drugs.com

(EN) Metoprolol Succinate Monograph for Professionals, su Drugs.com. URL consultato il 1º luglio 2020.

google.it

books.google.it

(EN) Pillay, Modern Medical Toxicology, Jaypee Brothers Publishers, 30 novembre 2012, ISBN 978-93-5025-965-8. URL consultato il 1º luglio 2020.
(EN) Richard C. Dart, Medical Toxicology, Lippincott Williams & Wilkins, 2004, ISBN 978-0-7817-2845-4. URL consultato il 1º luglio 2020.
(EN) B. Carlsson, Technological Systems and Industrial Dynamics, Springer Science & Business Media, 30 giugno 1997, ISBN 978-0-7923-9972-8. URL consultato il 1º luglio 2020.
(EN) IUPAC, János Fischer e C. Robin Ganellin, Analogue-based Drug Discovery, John Wiley & Sons, 13 dicembre 2006, ISBN 978-3-527-60749-5. URL consultato il 1º luglio 2020.

nih.gov

ncbi.nlm.nih.gov

G. Olsson, J. Wikstrand; I. Warnold; V. Manger Cats; D. McBoyle; J. Herlitz; A. Hjalmarson; EH. Sonneblick, Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials., in Eur Heart J, vol. 13, n. 1, Gen 1992, pp. 28-32, PMID 1533587.
A. Hjalmarson, B. Fagerberg, MERIT-HF mortality and morbidity data., in Basic Res Cardiol, 95 Suppl 1, 2000, pp. I98-103, PMID 11192362.
HC. Swaisland, M. Ranson; RP. Smith; J. Leadbetter; A. Laight; D. McKillop; MJ. Wild, Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol., in Clin Pharmacokinet, vol. 44, n. 10, 2005, pp. 1067-81, DOI:10.2165/00003088-200544100-00005, PMID 16176119.
CM. Blake, ED. Kharasch; M. Schwab; P. Nagele, A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics., in Clin Pharmacol Ther, vol. 94, n. 3, Set 2013, pp. 394-9, DOI:10.1038/clpt.2013.96, PMID 23665868.
CG. Regårdh, G. Johnsson, Clinical pharmacokinetics of metoprolol., in Clin Pharmacokinet, vol. 5, n. 6, pp. 557-69, PMID 7002420.
V. Kühlkamp, A. Schirdewan; K. Stangl; M. Homberg; M. Ploch; OA. Beck, Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study., in J Am Coll Cardiol, vol. 36, n. 1, Lug 2000, pp. 139-46, PMID 10898425.
PB. Hazard, CR. Burnett, Treatment of multifocal atrial tachycardia with metoprolol., in Crit Care Med, vol. 15, n. 1, Gen 1987, pp. 20-5, PMID 3792010.
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), in Lancet, vol. 353, n. 9169, Giu 1999, pp. 2001-7, PMID 10376614.
SD. Silberstein, S. Holland; F. Freitag; DW. Dodick; C. Argoff; E. Ashman, Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society., in Neurology, vol. 78, n. 17, Apr 2012, pp. 1337-45, DOI:10.1212/WNL.0b013e3182535d20, PMID 22529202.
RS. Bahn Chair, HB. Burch; DS. Cooper; JR. Garber; MC. Greenlee; I. Klein; P. Laurberg; IR. McDougall; VM. Montori; SA. Rivkees; DS. Ross, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists., in Thyroid, vol. 21, n. 6, Giu 2011, pp. 593-646, DOI:10.1089/thy.2010.0417, PMID 21510801.
DL. Geffner, JM. Hershman, Beta-adrenergic blockade for the treatment of hyperthyroidism., in Am J Med, vol. 93, n. 1, Lug 1992, pp. 61-8, PMID 1352658.
M. Biffi, G. Boriani; P. Sabbatani; G. Bronzetti; L. Frabetti; R. Zannoli; A. Branzi; B. Magnani, Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine., in Heart, vol. 77, n. 3, Mar 1997, pp. 268-72, PMID 9093048.
Q. Zhang, H. Jin; L. Wang; J. Chen; C. Tang; J. Du, Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents., in Med Sci Monit, vol. 14, n. 4, Apr 2008, pp. CR199-203, PMID 18376348.
AI. Ahmed, P. van Mierlo; P. Jansen, Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol., in Gen Hosp Psychiatry, vol. 32, n. 6, pp. 646.e5-7, DOI:10.1016/j.genhosppsych.2010.04.008, PMID 21112460.
AI. Ahmed, PJ. van Mierlo; JA. van Waarde; PA. Jansen, [Hallucinations and vivid dreams by use of metoprolol]., in Tijdschr Psychiatr, vol. 52, n. 2, 2010, pp. 117-21, PMID 20146183.
G. Boriani, M. Biffi; E. Strocchi; A. Branzi, Nightmares and sleep disturbances with simvastatin and metoprolol., in Ann Pharmacother, vol. 35, n. 10, Ott 2001, p. 1292, PMID 11675864.
JR. Cove-Smith, CA. Kirk, CNS-related side-effects with metoprolol and atenolol., in Eur J Clin Pharmacol, 28 Suppl, 1985, pp. 69-72, PMID 4054193.

oadoi.org

HC. Swaisland, M. Ranson; RP. Smith; J. Leadbetter; A. Laight; D. McKillop; MJ. Wild, Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol., in Clin Pharmacokinet, vol. 44, n. 10, 2005, pp. 1067-81, DOI:10.2165/00003088-200544100-00005, PMID 16176119.
CM. Blake, ED. Kharasch; M. Schwab; P. Nagele, A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics., in Clin Pharmacol Ther, vol. 94, n. 3, Set 2013, pp. 394-9, DOI:10.1038/clpt.2013.96, PMID 23665868.
SD. Silberstein, S. Holland; F. Freitag; DW. Dodick; C. Argoff; E. Ashman, Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society., in Neurology, vol. 78, n. 17, Apr 2012, pp. 1337-45, DOI:10.1212/WNL.0b013e3182535d20, PMID 22529202.
RS. Bahn Chair, HB. Burch; DS. Cooper; JR. Garber; MC. Greenlee; I. Klein; P. Laurberg; IR. McDougall; VM. Montori; SA. Rivkees; DS. Ross, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists., in Thyroid, vol. 21, n. 6, Giu 2011, pp. 593-646, DOI:10.1089/thy.2010.0417, PMID 21510801.
AI. Ahmed, P. van Mierlo; P. Jansen, Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol., in Gen Hosp Psychiatry, vol. 32, n. 6, pp. 646.e5-7, DOI:10.1016/j.genhosppsych.2010.04.008, PMID 21112460.

tga.gov.au

(EN) Australian Government Department of Health Therapeutic Goods Administration, Prescribing medicines in pregnancy database, su Therapeutic Goods Administration (TGA), 2 giugno 2020. URL consultato il 1º luglio 2020.

who.int

apps.who.int

(EN) World Health Organization, World Health Organization model list of essential medicines: 21st list 2019, 2019. URL consultato il 1º luglio 2020.